Pharmaceutical Business review

Ocera raises $35.5 million in series C financing

To date, Ocera has raised a total of $62 million. In conjunction with the financing, Linda Grais of InterWest Partners will take a seat on the Ocera board of directors representing Montagu Newhall Associates and the series C investors.

Laurent Fischer, co-founder, president and CEO of Ocera, said: “We are privileged to have attracted a syndicate of renowned investors with specific expertise in the gastrointestinal market as well as international and crossover investors and we welcome Linda Grais’s guidance as she joins our board of directors.”